Rare disease is a complex area and one the pharmaceutical industry has been heavily criticized on.
This Sifted/Financial Times story tells how Roche is transforming its #raredisease unit, by establishing a relationship with rare disease patient communities, helping these communities around the world and making them part of the company’s ecosystem.
